Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | GAA | P10253 | 2/20 | 0.59 |
| ▸ | ACHE | P22303 | 1/20 | 0.59 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.58 |
| ▸ | RAB9A | P51151 | 3/20 | 0.56 |
| ▸ | NPC1 | O15118 | 2/20 | 0.55 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.55 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5872163 | 0.98 | L3MBTL1 (0.71) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL2132367 | 0.95 | L3MBTL1 (0.60) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL5872083 | 0.89 | L3MBTL1 (0.67) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL11513541 | 0.87 | NPC1 (0.58) | L3MBTL1GAAACHEMCHR1RAB9A | |
| SCHEMBL8882276 | 0.85 | L3MBTL1 (0.57) | L3MBTL1SMN1; SMN2GAAACHERAB9A | |
| SCHEMBL4093054 | 0.85 | MCHR1 (0.51) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL8899205 | 0.83 | HRH3 (0.57) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL11323025 | 0.83 | L3MBTL1 (0.51) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| 2-Pyrrolidone SCHEMBL11038232 | 0.82 | L3MBTL1 (0.48) | L3MBTL1SMN1; SMN2GAAACHEMCHR1 | |
| SCHEMBL596252 | 0.82 | L3MBTL1 (0.96) | L3MBTL1SMN1; SMN2GAAACHERAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250206884-A1 | ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL | TAICA CORPORATION (JP) | 2025-06-26 | — | — | US | disclosed |
| CN-114763335-B | 4-Amide piperidine derivative and preparation method and application thereof | 江苏谛奇医药科技有限公司 | 2025-03-18 | — | — | CN | disclosed |
| WO-2023189433-A1 | ULTRAVIOLET RADIATION-CURABLE POLYSILOXANE COMPOSITION, AND DAMPING MATERIAL | 株式会社タイカ | 2023-10-05 | — | — | WO | disclosed |
| CN-110456087-B | Sertraline detection reagent and preparation and use methods thereof | 苏州博源医疗科技有限公司 | 2022-09-20 | — | — | CN | disclosed |
| CN-114763335-A | 4-amide piperidine derivative and preparation method and application thereof | 江苏谛奇医药科技有限公司 | 2022-07-19 | — | — | CN | disclosed |
| CN-114751834-A | Venlafaxine derivative, immunogen, anti-venlafaxine specific antibody, and preparation method and application thereof | 长沙博源医疗科技有限公司 | 2022-07-15 | — | — | CN | disclosed |
| CN-114685400-A | Aripiprazole key group derivative, immunogen, anti-aripiprazole specific antibody, and preparation method and application thereof | 苏州博源医疗科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685477-A | Linezolid derivative, immunogen, anti-linezolid specific antibody, and preparation method and application thereof | 苏州博源医疗科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685342-A | Levetiracetam derivative, immunogen, anti-levetiracetam specific antibody, preparation method and application thereof | 长沙博源医疗科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114685527-A | Olanzapine derivative, immunogen, anti-olanzapine specific antibody, preparation method and application thereof | 苏州博源医疗科技有限公司 | 2022-07-01 | — | — | CN | disclosed |
| US-20080132540-A1 | NON-PEPTIDIC NPY Y2 RECEPTOR INHIBITORS | CARRUTHERS NICHOLAS I | 2008-06-05 | — | — | US | disclosed |
| US-7317025-B2 | Non-peptidic NPY Y2 receptor inhibitors | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, LLC (US) | 2008-01-08 | — | — | US | disclosed |
| CN-1699349-A | Method and reagents for N-alkylating ureides | TARO PHARMA IND (IL) | 2005-11-23 | — | — | CN | disclosed |
| WO-2005030754-A1 | INDOLE OR QUINOLINE DERIVATIVES AS NON-PEPTICID NPY Y2 RECEPTOR INHIBITORS USEFUL FOR THE TREATMENT OF ANXIOLYTIC AND DEPRESSIVE DISORDERS AND OBESITY | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-04-07 | — | — | WO | disclosed |
| US-20050070534-A1 | Non-peptidic NPY Y2 receptor inhibitors | JANSSEN PHARMACEUTICA, N.V. (BE) | 2005-03-31 | — | — | US | disclosed |
| CN-1273581-A | Process and reagent for N-alkylation of ureides | TARO PHARMA IND (IL) | 2000-11-15 | — | — | CN | disclosed |
| WO-1999032488-A1 | METHOD FOR PREPARING A HYDANTOIN DERIVATIVE SUBSTITUTED IN POSITION 5, METHOD FOR PREPARING AN α-AMINO ACID ALKALINE SALT FROM SAID HYDANTOIN DERIVATIVE AND METHOD FOR ESTERIFYING CYCLIC α-AMINO ACIDS | SERANALIS (FR) | 1999-07-01 | — | — | WO | disclosed |
| US-4900738-A | OPIOID ANTAGONISTS; REDUCE SIDE EFFECTS | BOC, INC. (US) | 1990-02-13 | — | — | US | disclosed |
| US-4791112-A | ANALGESICS, NAQRCOTIC ANTAGONISTS | THE BOC GROUP, INC. (US) | 1988-12-13 | — | — | US | disclosed |
| US-4481360-A | 4H-1,2,4-Triazol-3-yl compounds | THE UPJOHN COMPANY (US) | 1984-11-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132540-A1 | NON-PEPTIDIC NPY Y2 RECEPTOR INHIBITORS | NPY2R, NPY1R, NPY5R | L3MBTL1 1163/4885SMN1; SMN2 1933/4885GAA 3862/4885 |
| US-20050070534-A1 | Non-peptidic NPY Y2 receptor inhibitors | NPY2R, NPY1R, NPY5R | L3MBTL1 1163/4885SMN1; SMN2 1933/4885GAA 3862/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.